0001752724-21-001932.txt : 20210113 0001752724-21-001932.hdr.sgml : 20210113 20210113161536 ACCESSION NUMBER: 0001752724-21-001932 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201031 FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALGER GLOBAL FOCUS FUND CENTRAL INDEX KEY: 0001219064 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21308 FILM NUMBER: 21526240 BUSINESS ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-806-8833 MAIL ADDRESS: STREET 1: 360 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ALGER GLOBAL GROWTH FUND DATE OF NAME CHANGE: 20130610 FORMER COMPANY: FORMER CONFORMED NAME: ALGER CHINA-US GROWTH FUND DATE OF NAME CHANGE: 20080924 FORMER COMPANY: FORMER CONFORMED NAME: CHINA US GROWTH FUND DATE OF NAME CHANGE: 20040121 0001219064 S000009192 ALGER GLOBAL FOCUS FUND C000024981 ALGER GLOBAL FOCUS FUND CLASS A CHUSX C000060632 ALGER GLOBAL FOCUS FUND CLASS C CHUCX C000127110 ALGER GLOBAL FOCUS FUND CLASS I AFGIX C000127111 ALGER GLOBAL FOCUS FUND CLASS Z AFGZX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001219064 XXXXXXXX 811-21308 true false false N-1A true Alger Global Focus Fund 811-21308 0001219064 5493000R8VYGCU6Y1832 360 Park Avenue South NEW YORK 10010-1714 US-NY US 800-992-3863 BROWN BROTHERS HARRIMAN & CO. 50 Post Office Square BOSTON 02110-1543 617-772-1818 Books and records N N N-1A 1 Y Hilary M. Alger 001164468 Y Roger P. Cheever N/A N Stephen E. O'Neil N/A N Nathan E. Saint-Amand M.D. N/A N Charles F. Baird 004827821 N David Rosenberg N/A N Tina Payne N/A 360 Park Avenue South New York 10010-1714 XXXXXX N N N N N N FRED ALGER & COMPANY, LLC 008-15900 000005300 549300TITGLG7BXCGB39 Y N Deloitte & Touche LLP 34 549300FJV7IV1ZHGAV28 N N N N N N N Alger Global Focus Fund S000009192 5493000R8VYGCU6Y1832 N 4 0 0 N/A N N Y N N/A N/A N/A N/A Y Y N N Fred Alger Management, LLC 801-6709 000106750 549300TITGLG7BXCGB39 N UMB Fund Services, Inc. 084-05792 N/A N N N Refinitiv US LLC 213800HQORQAP68CJJ04 N N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N FRED ALGER MANAGEMENT, LLC 549300TITGLG7BXCGB39 Y N UMB Fund Services, Inc 084-05792 SEC file number N Y N FRED ALGER MANAGEMENT, LLC 549300TITGLG7BXCGB39 Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y N Fred Alger & Company, LLC 008-15900 000005300 549300TITGLG7BXCGB39 373.88 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 1667.48000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 3865.55000000 UBS Securities LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 3179.59000000 EXANE, INC. 008-49569 000041784 6SDWK6FV8H98XAGSYS75 6039.93000000 Goldman Sachs & Co, LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 10016.70000000 BNY MELLON CAPITAL MARKETS, LLC 008-35255 000017454 VJW2DOOHGDT6PR0ZRO63 2252.60000000 Citic Securities N/A N/A 213800YMG8YN4O5CX140 HK 11646.68000000 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 3141.76000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 3538.49000000 Jefferies LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 2071.38000000 55979.41000000 BERENBERG BANK Stiftung von 1990 N/A N/A 5299000WI2BXRB3KKL92 DE 210347.71000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 32076.00000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 180162.22000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 298106.28000000 720692.21000000 N 20938651.51000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 Alger_Global_Focus_Fund.txt AUDITOR'S LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the shareholders and the Board of Trustees of Alger Global Focus Fund: In planning and performing our audit of the financial statements of Alger Global Focus Fund (the "Trust") as of and for the year ended October 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Trust's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Trust is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A trust's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A trust's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the trust; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the trust are being made only in accordance with authorizations of management and directors of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a trust's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the trust's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Trust's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Trust's internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of October 31, 2020. This report is intended solely for the information and use of management and the Board of Trustees of the Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. Deloitte & Touche LLP New York, New York December 21, 2020